SCHEMBL4079370

SCHEMBL4079370

CC1=C(c2cccc(Cl)c2)C(=O)NC1=O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 14/20 0.57
GSK3A P49840 6/20 0.56
ADORA2A P29274 1/20 0.53
ADORA1 P30542 1/20 0.53
BRDT Q58F21 1/20 0.53
STK10 O94804 3/20 0.52
SLK Q9H2G2 3/20 0.52
CCNA2 P20248 1/20 0.50
CDK2 P24941 1/20 0.50
CCNA1 P78396 1/20 0.50
PGR P06401 1/20 0.44
CLK2 P49760 1/20 0.44
STK33 Q9BYT3 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
TLK1 Q9UKI8 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
TDP2 O95551 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132790 0.87 PTGS2 (0.44) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL3820556 0.85 GSK3B (0.52) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL3819171 0.83 GSK3B (0.51) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL30999908 0.82 GSK3B (0.55) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL3729848 0.82 CAMK2D (0.44) GSK3BPGRCLK4
SCHEMBL934146 0.82 GSK3B (0.65) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL3820693 0.81 GSK3B (0.63) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL28785378 0.79 GSK3B (0.54) GSK3BGSK3ASTK10SLKTDP2
SCHEMBL30999976 0.79 GSK3B (0.59) GSK3BGSK3AADORA2AADORA1BRDT
SCHEMBL3818590 0.78 GSK3B (0.51) GSK3BGSK3AADORA2AADORA1BRDT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874298-A4 METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO[3,1,0]HEXANES DOV PHARMACEUTICAL INC (US) 2009-08-05 EP disclosed
EP-1874298-A2 METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO[3,1,0]HEXANES DOV Pharmaceutical Inc. (US) 2008-01-09 EP disclosed
WO-2006096810-A2 METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO[3.1.0] HEXANES DOV PHARMACEUTICAL, INC. (US) 2006-09-14 WO disclosed
EP-0267574-A2 Heat resistant copolymer composition Sumitomo Dow Limited (JP) 1988-05-18 EP disclosed